This is a preview of subscription content, log in via an institution to check access.
References
NICE. NICE gives green light to eye condition treatment in final draft guidance. Media Release : 29 Aug 2013. Available from: URL: http://www.nice.org.uk
NICE. 'Breast cancer drug not cost-effective', says NICE. Media Release : 28 Aug 2013. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
NICE says yes to ocriplasmin. PharmacoEcon Outcomes News 686, 10 (2013). https://doi.org/10.1007/s40274-013-0697-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0697-7